Your browser doesn't support javascript.
loading
Targeted delivery of doxorubicin to cancer cells by a cruciform DNA nanostructure composed of AS1411 and FOXM1 aptamers.
Abnous, Khalil; Danesh, Noor Mohammad; Ramezani, Mohammad; Charbgoo, Fahimeh; Bahreyni, Amirhossein; Taghdisi, Seyed Mohammad.
Afiliação
  • Abnous K; a Pharmaceutical Research Center, Pharmaceutical Technology Institute , Mashhad University of Medical Sciences , Mashhad , Iran.
  • Danesh NM; b Department of Medicinal Chemistry, School of Pharmacy , Mashhad University of Medical Sciences , Mashhad , Iran.
  • Ramezani M; c Research Institute of Sciences and New Technology , Mashhad , Iran.
  • Charbgoo F; a Pharmaceutical Research Center, Pharmaceutical Technology Institute , Mashhad University of Medical Sciences , Mashhad , Iran.
  • Bahreyni A; a Pharmaceutical Research Center, Pharmaceutical Technology Institute , Mashhad University of Medical Sciences , Mashhad , Iran.
  • Taghdisi SM; a Pharmaceutical Research Center, Pharmaceutical Technology Institute , Mashhad University of Medical Sciences , Mashhad , Iran.
Expert Opin Drug Deliv ; 15(11): 1045-1052, 2018 11.
Article em En | MEDLINE | ID: mdl-30269603
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligodesoxirribonucleotídeos / Doxorrubicina / Sistemas de Liberação de Medicamentos / Adutos de DNA / Proteína Forkhead Box M1 Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligodesoxirribonucleotídeos / Doxorrubicina / Sistemas de Liberação de Medicamentos / Adutos de DNA / Proteína Forkhead Box M1 Idioma: En Ano de publicação: 2018 Tipo de documento: Article